Ethics of bioprinting

Last updated

Ethics of bioprinting is a sub-field of ethics concerning bioprinting. Some of the ethical issues surrounding bioprinting include equal access to treatment, clinical safety complications, and the enhancement of human body (Dodds 2015). [1] [2]

Contents

3D printing was invented by Charles Hull in the mid-1980s. [3] 3D printing is a process in additive manufacturing which uses a digital design to produce a physical copy. This process is carried out by a specific printer, which uses several layers in order to complete the design. However, bioprinting uses the ways of 3D printing to create things such as organs, tissues, cells, blood vessels, prosthetics and a broad range of other things that can be used in the medical field. [4] [5] [6] The ethics of bioprinting have been a topic of discussion as long as bioprinting has been popular. Ethics are moral principles that govern production, behavior, etc. [7]

Equal access to treatment

Bioprinting focuses on the individual care rather than developing a universal treatment plan for all patients. Personalized medicine is expensive and increases the disparity between the rich and poor. Since 3D printing is an individual treatment, the general public assumes that it may prevent people with financial issues from receiving care. However, bioprinting improves universal access to healthcare because it will eventually "bring down the time and cost" of treatment. [1] For example, prosthetic limbs and orthopedic surgery can be done in an efficient and inexpensive manner. People would not have to wait months for their prosthetics, which will ultimately decrease the medical expense. The bioprinter may be used to manufacture bone replacements and produce customized prosthetic limbs quickly. Also the printing of human organs, and tissues, are available with decreased time, only taking a few weeks to produce instead of a regular transplant. Currently in the United States, approximately 115,000 people are awaiting a transplant, which can take nearly two years to obtain, while nearly 2 million people have lost a limb. [8] [9] Those who were previously excluded from these medical advancements will now have access to them.

Safety

Any new treatment involving 3D printers is risky and patients must be well informed of the health implications. Doctors hope in the future to print organs in order to replace dysfunctional bio-structures. Similar to organ donations, the cells must match genetically otherwise the recipient's body will reject the organ. The patient would then have an autoimmune response and destroy the donated tissue. The individual's stem cells must be used to manufacture the organ for the specific patient. In order to advance this technology, the medical field must find a way to test and standardize organ production.

Human enhancement

Bioprinting may be used to increase human performance, strength, speed, or endurance. For instance, bioprinting may be used to manufacture enhanced bones and replace regular human bones that are stronger and more flexible. The 3D printer could also be used to increase muscle performance by making muscles more "resilient and less likely to become fatigued". [1] Lung capacity could also be improved by replacing it with an artificial lung that can increase oxygen efficiency in the blood. Human enhancement would have a dangerous but incredible impact on society; bioprinting could create a culture without disease or imperfection.

Legality and policies

Bioprinted items would require regulation to ensure safety and effectiveness. In the United States, this is the job of FDA. The FDA must make sure that printed organs are handled a bit differently than human organs because bioprinting is a new and developing treatment, and therefore little is known about its interactions with the human body. [10] Bioprinting faces trade-offs between restricted use and open use. Restricted use will allow bioprinting to only be done by trained professionals, whereas open use is more of a free-for-all. There are also trade-offs between if it is ethical to mass-produce organs or if it could make issues in transplant cases worse. Selling bioprinted organs may be illegal under existing laws meant to stop the blackmarket trade of human organs. [11]

Related Research Articles

<span class="mw-page-title-main">Biomedical engineering</span> Application of engineering principles and design concepts to medicine and biology

Biomedical engineering (BME) or medical engineering is the application of engineering principles and design concepts to medicine and biology for healthcare applications. BME is also traditionally logical sciences to advance health care treatment, including diagnosis, monitoring, and therapy. Also included under the scope of a biomedical engineer is the management of current medical equipment in hospitals while adhering to relevant industry standards. This involves procurement, routine testing, preventive maintenance, and making equipment recommendations, a role also known as a Biomedical Equipment Technician (BMET) or as a clinical engineer.

<span class="mw-page-title-main">Prosthesis</span> Artificial device that replaces a missing body part

In medicine, a prosthesis, or a prosthetic implant, is an artificial device that replaces a missing body part, which may be lost through physical trauma, disease, or a condition present at birth. Prostheses are intended to restore the normal functions of the missing body part. Amputee rehabilitation is primarily coordinated by a physiatrist as part of an inter-disciplinary team consisting of physiatrists, prosthetists, nurses, physical therapists, and occupational therapists. Prostheses can be created by hand or with computer-aided design (CAD), a software interface that helps creators design and analyze the creation with computer-generated 2-D and 3-D graphics as well as analysis and optimization tools.

An artificial organ is a human made organ device or tissue that is implanted or integrated into a human — interfacing with living tissue — to replace a natural organ, to duplicate or augment a specific function or functions so the patient may return to a normal life as soon as possible. The replaced function does not have to be related to life support, but it often is. For example, replacement bones and joints, such as those found in hip replacements, could also be considered artificial organs.

<span class="mw-page-title-main">Tissue engineering</span> Biomedical engineering discipline

Tissue engineering is a biomedical engineering discipline that uses a combination of cells, engineering, materials methods, and suitable biochemical and physicochemical factors to restore, maintain, improve, or replace different types of biological tissues. Tissue engineering often involves the use of cells placed on tissue scaffolds in the formation of new viable tissue for a medical purpose, but is not limited to applications involving cells and tissue scaffolds. While it was once categorized as a sub-field of biomaterials, having grown in scope and importance, it can is considered as a field of its own.

<span class="mw-page-title-main">Xenotransplantation</span> Transplantation of cells or tissue across species

Xenotransplantation, or heterologous transplant, is the transplantation of living cells, tissues or organs from one species to another. Such cells, tissues or organs are called xenografts or xenotransplants. It is contrasted with allotransplantation, syngeneic transplantation or isotransplantation and autotransplantation. Xenotransplantation is an artificial method of creating an animal-human chimera, that is, a human with a subset of animal cells. In contrast, an individual where each cell contains genetic material from a human and an animal is called a human–animal hybrid.

<span class="mw-page-title-main">Implant (medicine)</span> Device surgically placed within the body for medical purposes

An implant is a medical device manufactured to replace a missing biological structure, support a damaged biological structure, or enhance an existing biological structure. For example, an implant may be a rod, used to strengthen weak bones. Medical implants are human-made devices, in contrast to a transplant, which is a transplanted biomedical tissue. The surface of implants that contact the body might be made of a biomedical material such as titanium, silicone, or apatite depending on what is the most functional. In 2018, for example, American Elements developed a nickel alloy powder for 3D printing robust, long-lasting, and biocompatible medical implants. In some cases implants contain electronics, e.g. artificial pacemaker and cochlear implants. Some implants are bioactive, such as subcutaneous drug delivery devices in the form of implantable pills or drug-eluting stents.

<span class="mw-page-title-main">Organ printing</span> Method of creating artificial organs

Organ printing utilizes techniques similar to conventional 3D printing where a computer model is fed into a printer that lays down successive layers of plastics or wax until a 3D object is produced. In the case of organ printing, the material being used by the printer is a biocompatible plastic. The biocompatible plastic forms a scaffold that acts as the skeleton for the organ that is being printed. As the plastic is being laid down, it is also seeded with human cells from the patient's organ that is being printed for. After printing, the organ is transferred to an incubation chamber to give the cells time to grow. After a sufficient amount of time, the organ is implanted into the patient.

The Wake Forest Institute for Regenerative Medicine (WFIRM) is a research institute affiliated with Wake Forest School of Medicine and located in Winston-Salem, North Carolina, United States

<span class="mw-page-title-main">Nose prosthesis</span>

A nose prosthesis is a craniofacial prosthesis for someone who no longer has their original nose. Nose prostheses are designed by anaplastologists who have their patients referred to them by ear, nose, and throat doctors and plastic surgeons.

<span class="mw-page-title-main">Methuselah Foundation</span> U.S. nonprofit organization

The Methuselah Foundation is an American-based global non-profit organization based in Springfield, Virginia, with a declared mission to "make 90 the new 50 by 2030" by supporting tissue engineering and regenerative medicine therapies. The organization was originally incorporated by David Gobel in 2001 as the Performance Prize Society, a name inspired by the British governments Longitude Act, which offered monetary rewards for anyone who could devise a portable, practical solution for determining a ship's longitude.

<span class="mw-page-title-main">United Therapeutics</span> American biotech company based in Maryland

United Therapeutics Corporation is an American publicly traded biotechnology company and public benefit corporation listed on the NASDAQ under the symbol UTHR. It develops novel, life-extending technologies for patients in the areas of lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire.

<span class="mw-page-title-main">3D bioprinting</span> Utilization of 3D printing to fabricate biomedical parts

Three dimensional (3D) bioprinting is the utilization of 3D printing–like techniques to combine cells, growth factors, bio-inks, and biomaterials to fabricate functional structures that were traditionally used for tissue engineering applications but in recent times have seen increased interest in other applications such as biosensing, and environmental remediation. Generally, 3D bioprinting utilizes a layer-by-layer method to deposit materials known as bio-inks to create tissue-like structures that are later used in various medical and tissue engineering fields. 3D bioprinting covers a broad range of bioprinting techniques and biomaterials. Currently, bioprinting can be used to print tissue and organ models to help research drugs and potential treatments. Nonetheless, translation of bioprinted living cellular constructs into clinical application is met with several issues due to the complexity and cell number necessary to create functional organs. However, innovations span from bioprinting of extracellular matrix to mixing cells with hydrogels deposited layer by layer to produce the desired tissue. In addition, 3D bioprinting has begun to incorporate the printing of scaffolds which can be used to regenerate joints and ligaments. Apart from these, 3D bioprinting has recently been used in environmental remediation applications, including the fabrication of functional biofilms that host functional microorganisms that can facilitate pollutant removal.

In bioethics, ethics of organ transplantation refers to the ethical concerns on organ transplantation procedures. Both the source and method of obtaining the organ to transplant are major ethical issues to consider, as well as the notion of distributive justice.

Organovo Holdings, Inc. is an early-stage medical laboratory and research company which designs and develops functional, three dimensional human tissue for medical research and therapeutic applications. Organovo was established in 2007 and is headquartered in San Diego, California. The company uses its internally developed NovoGen MMX Bioprinter for 3D bioprinting.

Bio-inks are materials used to produce engineered/artificial live tissue using 3D printing. These inks are mostly composed of the cells that are being used, but are often used in tandem with additional materials that envelope the cells. The combination of cells and usually biopolymer gels are defined as a bio-ink. They must meet certain characteristics, including such as rheological, mechanical, biofunctional and biocompatibility properties, among others. Using bio-inks provides a high reproducibility and precise control over the fabricated constructs in an automated manner. These inks are considered as one of the most advanced tools for tissue engineering and regenerative medicine (TERM).

<span class="mw-page-title-main">Applications of 3D printing</span>

In recent years, 3D printing has developed significantly and can now perform crucial roles in many applications, with the most common applications being manufacturing, medicine, architecture, custom art and design, and can vary from fully functional to purely aesthetic applications.

Bico Group is a bioconvergence startup that designs and supplies technologies and services to enhance biology research. It focuses on commercializing technologies for life science research as well as bioprinting, and its products often combine capabilities in artificial intelligence, robotics, multiomics, and diagnostics.

Due to the many regulations in the industry, the design of medical devices presents significant challenges from both engineering and legal perspectives.

<span class="mw-page-title-main">Microgravity bioprinting</span>

Microgravity bioprinting is the utilization of 3D bioprinting techniques under microgravity conditions to fabricate highly complex, functional tissue and organ structures. The zero gravity environment circumvents some of the current limitations of bioprinting on Earth including magnetic field disruption and biostructure retention during the printing process. Microgravity bioprinting is one of the initial steps to advancing in space exploration and colonization while furthering the possibilities of regenerative medicine.

Bioprinting drug delivery is a method for producing drug delivery vehicles. It uses three-dimensional printing of biomaterials via additive manufacturing. Such vehicles are biocompatible, tissue-specific hydrogels or implantable devices. 3D bioprinting prints cells and biological molecules to form tissues, organs, or biological materials in a scaffold-free manner that mimics living human tissue. The technique allows targeted disease treatments with scalable and complex geometry.

References

  1. 1 2 3 Dodds, Susan (11 February 2015). "3D printing raises ethical issues in medicine". ABC Science.
  2. ↑ Williams, Rhiannon (29 January 2014). "3D printing human tissue and organs to 'spark ethics debate'". The Telegraph.
  3. ↑ "What is 3D Printing? The definitive guide". 3D Hubs. Retrieved 2018-05-06.
  4. ↑ "What is Bioprinting?". www.innovateus.net. Retrieved 2018-05-06.
  5. ↑ "ExplainingTheFuture.com : Bioprinting". www.explainingthefuture.com. Retrieved 2018-05-06.
  6. ↑ Lim, Alane (May 2, 2018). "What is Bioprinting?". ThoughtCo. Retrieved September 17, 2019.
  7. ↑ University, Santa Clara. "What is Ethics? - Markkula Center for Applied Ethics". www.scu.edu. Retrieved 2018-05-06.
  8. ↑ "Limb Loss Statistics - Amputee Coalition". Amputee Coalition. Retrieved 2018-05-06.
  9. ↑ "Facts and Myths – American Transplant Foundation". www.americantransplantfoundation.org. Retrieved 2018-05-06.
  10. ↑ Kelly, Elizabeth. "FDA Regulation of 3D Printed Organs and Associated Ethical Challenges" (PDF). Archived from the original (PDF) on February 6, 2018.
  11. ↑ Vermeulen, Niki; Haddow, Gill; Seymour, Tirion; Faulkner-Jones, Alan; Shu, Wenmiao (2017-03-20). "3D bioprint me: a socioethical view of bioprinting human organs and tissues". Journal of Medical Ethics. 43 (9): medethics–2015–103347. doi:10.1136/medethics-2015-103347. ISSN   0306-6800. PMC   5827711 . PMID   28320774.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.